MicroRNA-Based Liquid Biopsy for Cervical Cancer Diagnostics and Treatment Monitoring

Despite prevention strategies, cervical cancer remains a significant public health issue. Human papillomavirus plays a critical role in its development, and early detection is vital to improve patient outcomes. The incidence of cervical cancer is projected to rise, necessitating better diagnostic to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of molecular sciences 2024-12, Vol.25 (24), p.13271
Hauptverfasser: Kepsha, Maria A, Timofeeva, Angelika V, Chernyshev, Vasiliy S, Silachev, Denis N, Mezhevitinova, Elena A, Sukhikh, Gennadiy T
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 24
container_start_page 13271
container_title International journal of molecular sciences
container_volume 25
creator Kepsha, Maria A
Timofeeva, Angelika V
Chernyshev, Vasiliy S
Silachev, Denis N
Mezhevitinova, Elena A
Sukhikh, Gennadiy T
description Despite prevention strategies, cervical cancer remains a significant public health issue. Human papillomavirus plays a critical role in its development, and early detection is vital to improve patient outcomes. The incidence of cervical cancer is projected to rise, necessitating better diagnostic tools. Traditional screening methods like the cytological examination and human papillomavirus testing have limitations in sensitivity and reproducibility. Liquid-based cytology offers some improvements, but the need for more reliable and sensitive techniques persists, particularly for detecting precancerous lesions. Liquid biopsy is a non-invasive method that analyzes cancer-derived products in biofluids like blood, offering potential for real-time monitoring of tumor progression, metastasis, and treatment response. It can be based on detection of circulating tumor cells (CTCs), circulating free DNA (cfDNA), and microRNAs (miRNAs). This review particularly underlines the potential of microRNAs, which are transported by extracellular vesicles. Overall, this article underscores the importance of continued research into non-invasive diagnostic methods like liquid biopsy to enhance cervical cancer screening and treatment monitoring.
doi_str_mv 10.3390/ijms252413271
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_3153868755</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A821834403</galeid><sourcerecordid>A821834403</sourcerecordid><originalsourceid>FETCH-LOGICAL-c274t-cf023d1c9fc2cc535c87660f9d0f76daec4ffe16f004cf57ebeeb3faad14aa633</originalsourceid><addsrcrecordid>eNptkctLJDEQxsOirLO6R68S8OKlNe_uPs6M-4JRQWbOTSapDBm6kzHpFvzvtwcfu4rUoYri9xUf9SF0Sskl5zW58tsuM8kE5aykX9CECsYKQlR58N98hL7lvCWEcSbrr-iI16WqCVcTtLrxJsX722kx0xksXviHwVs883GXn7CLCc8hPXqjWzzXwUDC115vQsy9NxnrYPEyge47CD2-icH3MfmwOUGHTrcZvr_0Y7T6-WM5_10s7n79mU8XhWGl6AvjRkeWmtoZZozk0lSlUsTVlrhSWQ1GOAdUOUKEcbKENcCaO60tFVorzo_RxfPdXYoPA-S-6Xw20LY6QBxyw6nklapKKUf0_AO6jUMKo7uRErWShNb8H7XRLTQ-uNgnbfZHm2nFaMWFIHvq8hNqLAudNzGA8-P-naB4Foy_zjmBa3bJdzo9NZQ0-xibdzGO_NmL2WHdgX2jX3PjfwG9TZcy</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3149650193</pqid></control><display><type>article</type><title>MicroRNA-Based Liquid Biopsy for Cervical Cancer Diagnostics and Treatment Monitoring</title><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Kepsha, Maria A ; Timofeeva, Angelika V ; Chernyshev, Vasiliy S ; Silachev, Denis N ; Mezhevitinova, Elena A ; Sukhikh, Gennadiy T</creator><creatorcontrib>Kepsha, Maria A ; Timofeeva, Angelika V ; Chernyshev, Vasiliy S ; Silachev, Denis N ; Mezhevitinova, Elena A ; Sukhikh, Gennadiy T</creatorcontrib><description>Despite prevention strategies, cervical cancer remains a significant public health issue. Human papillomavirus plays a critical role in its development, and early detection is vital to improve patient outcomes. The incidence of cervical cancer is projected to rise, necessitating better diagnostic tools. Traditional screening methods like the cytological examination and human papillomavirus testing have limitations in sensitivity and reproducibility. Liquid-based cytology offers some improvements, but the need for more reliable and sensitive techniques persists, particularly for detecting precancerous lesions. Liquid biopsy is a non-invasive method that analyzes cancer-derived products in biofluids like blood, offering potential for real-time monitoring of tumor progression, metastasis, and treatment response. It can be based on detection of circulating tumor cells (CTCs), circulating free DNA (cfDNA), and microRNAs (miRNAs). This review particularly underlines the potential of microRNAs, which are transported by extracellular vesicles. Overall, this article underscores the importance of continued research into non-invasive diagnostic methods like liquid biopsy to enhance cervical cancer screening and treatment monitoring.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms252413271</identifier><identifier>PMID: 39769036</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Angiogenesis ; Biomarkers ; Biomarkers, Tumor - genetics ; Biopsy ; Cancer ; Care and treatment ; Cellular biology ; Cervical cancer ; Cervix ; Development and progression ; Disease ; Drug therapy ; Early Detection of Cancer - methods ; Female ; Health aspects ; Human Development Index ; Human papillomavirus ; Humans ; Liquid Biopsy - methods ; Medical screening ; Metastasis ; MicroRNA ; MicroRNAs - blood ; MicroRNAs - genetics ; Mortality ; Neoplastic Cells, Circulating - metabolism ; Neoplastic Cells, Circulating - pathology ; Oncology, Experimental ; Pap smear ; Patients ; Prevention ; Public health ; Uterine Cervical Neoplasms - diagnosis ; Uterine Cervical Neoplasms - genetics ; Uterine Cervical Neoplasms - therapy ; Womens health</subject><ispartof>International journal of molecular sciences, 2024-12, Vol.25 (24), p.13271</ispartof><rights>COPYRIGHT 2024 MDPI AG</rights><rights>2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c274t-cf023d1c9fc2cc535c87660f9d0f76daec4ffe16f004cf57ebeeb3faad14aa633</cites><orcidid>0000-0003-2324-9653 ; 0000-0003-0581-9755</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39769036$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kepsha, Maria A</creatorcontrib><creatorcontrib>Timofeeva, Angelika V</creatorcontrib><creatorcontrib>Chernyshev, Vasiliy S</creatorcontrib><creatorcontrib>Silachev, Denis N</creatorcontrib><creatorcontrib>Mezhevitinova, Elena A</creatorcontrib><creatorcontrib>Sukhikh, Gennadiy T</creatorcontrib><title>MicroRNA-Based Liquid Biopsy for Cervical Cancer Diagnostics and Treatment Monitoring</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>Despite prevention strategies, cervical cancer remains a significant public health issue. Human papillomavirus plays a critical role in its development, and early detection is vital to improve patient outcomes. The incidence of cervical cancer is projected to rise, necessitating better diagnostic tools. Traditional screening methods like the cytological examination and human papillomavirus testing have limitations in sensitivity and reproducibility. Liquid-based cytology offers some improvements, but the need for more reliable and sensitive techniques persists, particularly for detecting precancerous lesions. Liquid biopsy is a non-invasive method that analyzes cancer-derived products in biofluids like blood, offering potential for real-time monitoring of tumor progression, metastasis, and treatment response. It can be based on detection of circulating tumor cells (CTCs), circulating free DNA (cfDNA), and microRNAs (miRNAs). This review particularly underlines the potential of microRNAs, which are transported by extracellular vesicles. Overall, this article underscores the importance of continued research into non-invasive diagnostic methods like liquid biopsy to enhance cervical cancer screening and treatment monitoring.</description><subject>Angiogenesis</subject><subject>Biomarkers</subject><subject>Biomarkers, Tumor - genetics</subject><subject>Biopsy</subject><subject>Cancer</subject><subject>Care and treatment</subject><subject>Cellular biology</subject><subject>Cervical cancer</subject><subject>Cervix</subject><subject>Development and progression</subject><subject>Disease</subject><subject>Drug therapy</subject><subject>Early Detection of Cancer - methods</subject><subject>Female</subject><subject>Health aspects</subject><subject>Human Development Index</subject><subject>Human papillomavirus</subject><subject>Humans</subject><subject>Liquid Biopsy - methods</subject><subject>Medical screening</subject><subject>Metastasis</subject><subject>MicroRNA</subject><subject>MicroRNAs - blood</subject><subject>MicroRNAs - genetics</subject><subject>Mortality</subject><subject>Neoplastic Cells, Circulating - metabolism</subject><subject>Neoplastic Cells, Circulating - pathology</subject><subject>Oncology, Experimental</subject><subject>Pap smear</subject><subject>Patients</subject><subject>Prevention</subject><subject>Public health</subject><subject>Uterine Cervical Neoplasms - diagnosis</subject><subject>Uterine Cervical Neoplasms - genetics</subject><subject>Uterine Cervical Neoplasms - therapy</subject><subject>Womens health</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNptkctLJDEQxsOirLO6R68S8OKlNe_uPs6M-4JRQWbOTSapDBm6kzHpFvzvtwcfu4rUoYri9xUf9SF0Sskl5zW58tsuM8kE5aykX9CECsYKQlR58N98hL7lvCWEcSbrr-iI16WqCVcTtLrxJsX722kx0xksXviHwVs883GXn7CLCc8hPXqjWzzXwUDC115vQsy9NxnrYPEyge47CD2-icH3MfmwOUGHTrcZvr_0Y7T6-WM5_10s7n79mU8XhWGl6AvjRkeWmtoZZozk0lSlUsTVlrhSWQ1GOAdUOUKEcbKENcCaO60tFVorzo_RxfPdXYoPA-S-6Xw20LY6QBxyw6nklapKKUf0_AO6jUMKo7uRErWShNb8H7XRLTQ-uNgnbfZHm2nFaMWFIHvq8hNqLAudNzGA8-P-naB4Foy_zjmBa3bJdzo9NZQ0-xibdzGO_NmL2WHdgX2jX3PjfwG9TZcy</recordid><startdate>20241210</startdate><enddate>20241210</enddate><creator>Kepsha, Maria A</creator><creator>Timofeeva, Angelika V</creator><creator>Chernyshev, Vasiliy S</creator><creator>Silachev, Denis N</creator><creator>Mezhevitinova, Elena A</creator><creator>Sukhikh, Gennadiy T</creator><general>MDPI AG</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-2324-9653</orcidid><orcidid>https://orcid.org/0000-0003-0581-9755</orcidid></search><sort><creationdate>20241210</creationdate><title>MicroRNA-Based Liquid Biopsy for Cervical Cancer Diagnostics and Treatment Monitoring</title><author>Kepsha, Maria A ; Timofeeva, Angelika V ; Chernyshev, Vasiliy S ; Silachev, Denis N ; Mezhevitinova, Elena A ; Sukhikh, Gennadiy T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c274t-cf023d1c9fc2cc535c87660f9d0f76daec4ffe16f004cf57ebeeb3faad14aa633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Angiogenesis</topic><topic>Biomarkers</topic><topic>Biomarkers, Tumor - genetics</topic><topic>Biopsy</topic><topic>Cancer</topic><topic>Care and treatment</topic><topic>Cellular biology</topic><topic>Cervical cancer</topic><topic>Cervix</topic><topic>Development and progression</topic><topic>Disease</topic><topic>Drug therapy</topic><topic>Early Detection of Cancer - methods</topic><topic>Female</topic><topic>Health aspects</topic><topic>Human Development Index</topic><topic>Human papillomavirus</topic><topic>Humans</topic><topic>Liquid Biopsy - methods</topic><topic>Medical screening</topic><topic>Metastasis</topic><topic>MicroRNA</topic><topic>MicroRNAs - blood</topic><topic>MicroRNAs - genetics</topic><topic>Mortality</topic><topic>Neoplastic Cells, Circulating - metabolism</topic><topic>Neoplastic Cells, Circulating - pathology</topic><topic>Oncology, Experimental</topic><topic>Pap smear</topic><topic>Patients</topic><topic>Prevention</topic><topic>Public health</topic><topic>Uterine Cervical Neoplasms - diagnosis</topic><topic>Uterine Cervical Neoplasms - genetics</topic><topic>Uterine Cervical Neoplasms - therapy</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kepsha, Maria A</creatorcontrib><creatorcontrib>Timofeeva, Angelika V</creatorcontrib><creatorcontrib>Chernyshev, Vasiliy S</creatorcontrib><creatorcontrib>Silachev, Denis N</creatorcontrib><creatorcontrib>Mezhevitinova, Elena A</creatorcontrib><creatorcontrib>Sukhikh, Gennadiy T</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kepsha, Maria A</au><au>Timofeeva, Angelika V</au><au>Chernyshev, Vasiliy S</au><au>Silachev, Denis N</au><au>Mezhevitinova, Elena A</au><au>Sukhikh, Gennadiy T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>MicroRNA-Based Liquid Biopsy for Cervical Cancer Diagnostics and Treatment Monitoring</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2024-12-10</date><risdate>2024</risdate><volume>25</volume><issue>24</issue><spage>13271</spage><pages>13271-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>Despite prevention strategies, cervical cancer remains a significant public health issue. Human papillomavirus plays a critical role in its development, and early detection is vital to improve patient outcomes. The incidence of cervical cancer is projected to rise, necessitating better diagnostic tools. Traditional screening methods like the cytological examination and human papillomavirus testing have limitations in sensitivity and reproducibility. Liquid-based cytology offers some improvements, but the need for more reliable and sensitive techniques persists, particularly for detecting precancerous lesions. Liquid biopsy is a non-invasive method that analyzes cancer-derived products in biofluids like blood, offering potential for real-time monitoring of tumor progression, metastasis, and treatment response. It can be based on detection of circulating tumor cells (CTCs), circulating free DNA (cfDNA), and microRNAs (miRNAs). This review particularly underlines the potential of microRNAs, which are transported by extracellular vesicles. Overall, this article underscores the importance of continued research into non-invasive diagnostic methods like liquid biopsy to enhance cervical cancer screening and treatment monitoring.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>39769036</pmid><doi>10.3390/ijms252413271</doi><orcidid>https://orcid.org/0000-0003-2324-9653</orcidid><orcidid>https://orcid.org/0000-0003-0581-9755</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1422-0067
ispartof International journal of molecular sciences, 2024-12, Vol.25 (24), p.13271
issn 1422-0067
1661-6596
1422-0067
language eng
recordid cdi_proquest_miscellaneous_3153868755
source MDPI - Multidisciplinary Digital Publishing Institute; MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Angiogenesis
Biomarkers
Biomarkers, Tumor - genetics
Biopsy
Cancer
Care and treatment
Cellular biology
Cervical cancer
Cervix
Development and progression
Disease
Drug therapy
Early Detection of Cancer - methods
Female
Health aspects
Human Development Index
Human papillomavirus
Humans
Liquid Biopsy - methods
Medical screening
Metastasis
MicroRNA
MicroRNAs - blood
MicroRNAs - genetics
Mortality
Neoplastic Cells, Circulating - metabolism
Neoplastic Cells, Circulating - pathology
Oncology, Experimental
Pap smear
Patients
Prevention
Public health
Uterine Cervical Neoplasms - diagnosis
Uterine Cervical Neoplasms - genetics
Uterine Cervical Neoplasms - therapy
Womens health
title MicroRNA-Based Liquid Biopsy for Cervical Cancer Diagnostics and Treatment Monitoring
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T04%3A58%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=MicroRNA-Based%20Liquid%20Biopsy%20for%20Cervical%20Cancer%20Diagnostics%20and%20Treatment%20Monitoring&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Kepsha,%20Maria%20A&rft.date=2024-12-10&rft.volume=25&rft.issue=24&rft.spage=13271&rft.pages=13271-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms252413271&rft_dat=%3Cgale_proqu%3EA821834403%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3149650193&rft_id=info:pmid/39769036&rft_galeid=A821834403&rfr_iscdi=true